Clinical Trial Update: A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 study exploring elacestrant alone or with abemaciclib in endometrial cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• Elacestrant (elacestrant)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Endometrial Cancer | Phase 2 | Status: RECRUITING